HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Darina L Lazarova Selected Research

Butyrates (Butyrate)

1/2017p300 Knockout Promotes Butyrate Resistance.
1/2016Effects of propolis and gamma-cyclodextrin on intestinal neoplasia in normal weight and obese mice.
1/2016Vimentin, colon cancer progression and resistance to butyrate and other HDACis.
7/2015CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
1/2015Hypothesis: cell signalling influences age-related risk of colorectal cancer.
4/2014Butyrate induced changes in Wnt-signaling specific gene expression in colorectal cancer cells.
1/2013p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells.
1/2013CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells.
11/2012Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.
6/2011The Notch ligand Delta-like 1 integrates inputs from TGFbeta/Activin and Wnt pathways.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Darina L Lazarova Research Topics

Disease

14Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 01/2004
7Colonic Neoplasms (Colon Cancer)
01/2016 - 01/2004
5Neoplasms (Cancer)
05/2016 - 01/2008
3Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2013 - 01/2002
2Adenoma (Adenomas)
01/2016 - 01/2014
2Carcinoma (Carcinomatosis)
01/2016 - 01/2002
1Sarcoma (Soft Tissue Sarcoma)
05/2016
1Hyperthermia
05/2016
1Neoplasm Metastasis (Metastasis)
01/2016
1Obesity
01/2016
1Polyps
01/2016
1Progeria (Hutchinson Gilford Syndrome)
01/2015
1Carcinogenesis
01/2013

Drug/Important Bio-Agent (IBA)

15Butyrates (Butyrate)IBA
01/2017 - 01/2002
6Dietary FiberFDA Link
01/2017 - 07/2004
6beta CateninIBA
05/2016 - 01/2002
6Calcibiotic Root Canal SealerIBA
01/2015 - 01/2004
3Histone Deacetylase InhibitorsIBA
01/2014 - 01/2011
2CateninsIBA
07/2015 - 01/2013
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2016
1gamma-cyclodextrinIBA
01/2016
1Propolis (Bee Bread)IBA
01/2016
1VimentinIBA
01/2016
1CREB-Binding ProteinIBA
07/2015
1Proteins (Proteins, Gene)FDA Link
01/2015
1Pharmaceutical PreparationsIBA
01/2014
1LigandsIBA
06/2011
1SolutionsIBA
05/2008
1Fatty Acids (Saturated Fatty Acids)IBA
07/2004
1LithiumIBA
01/2004
1Volatile Fatty AcidsIBA
01/2002
1Butyric Acid (Butanoic Acid)IBA
01/2002

Therapy/Procedure

2Therapeutics
05/2016 - 01/2014